Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(1.43) per share. This is a decrease over losses of $(0.73) per share from the same period last year. The company reported $1.32 million in sales this quarter. This is a 28.70 percent decrease over sales of $1.85 million the same period last year.
Posted In: NURO